Next-generation sequencing identifies a novel ELAVL1-TYK2 fusion gene in MOLM-16, an AML cell line highly sensitive to the PIM kinase inhibitor AZD1208

Leuk Lymphoma. 2016 Dec;57(12):2927-2929. doi: 10.3109/10428194.2016.1171861. Epub 2016 May 17.

Adriana E Tron¹, Erika K Keeton^{1

2}, Minwei Ye¹, Matias Casas-Selves^{1

3}, Huawei Chen¹, Keith S Dillman¹, Rosemary E Gale⁴, Chloe Stengel⁴, Michael Zinda¹, David C Linch⁴, Zhongwu Lai¹, Asim Khwaja⁴, Dennis Huszar^{1

5}

¹ a Oncology iMed, AstraZeneca , Waltham , MA , USA.
² b N-of-One, Inc , Lexington , MA , USA.
³ c Drug Discovery Program, Ontario Institute for Cancer Research , Toronto , Canada.
⁴ d Department of Haematology , University College London Cancer Institute , London , UK.
⁵ e Oncology Drug Discover Unit, Takeda Pharmaceuticals International Co , Cambridge , MA , USA.

No abstract available

Publication types